title: Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning.
abstract: Transcellular permeability of the neuroleptic-anesthetic chlorpromazine (CPZ) was examined using a cell type (MDCK) that forms a confluent monolayer of polarized cells resulting in distinct apical (AP) and basolateral (BL) membrane domains separated by tight junctions. Because CPZ is membrane interactive, transmonolayer flux was analyzed as two kinetic events: cell uptake from the AP donor solution and efflux into the BL side receiver. Using the rate of cell uptake in the presence of different concentrations of BSA, an intrinsic cell partition coefficient of 3700 +/- 130 and an operational dissociation binding constant of 0.4 +/- 0.05 mM were calculated. In contrast to uptake, efflux of CPZ from either the AP or the BL side of the cell monolayer was approximately 10(4)-fold slower and was dependent upon the avidity of CPZ for the protein acceptor in the receiver solution. These results emphasized the importance of simultaneously measuring disappearance of a lipophilic molecule from the donor solution and its appearance in the receiver and demonstrated how interactions with proteins on either side of the cellular barrier influence permeability. Appearance kinetics showed that the composition of the receiving environment is critical to model a particular in vivo situation and implied that the intrinsic permeability of membrane-interactive molecules in vitro does not necessarily predict penetration beyond the initial cellular barrier in vivo.
authors.affiliation: Upjohn Laboratories, Upjohn Company, Kalamazoo, Michigan 49007.
authors.forename: G A
authors.initials: GA
authors.lastname: Sawada
authors.forename: N F
authors.initials: NF
authors.lastname: Ho
authors.forename: L R
authors.initials: LR
authors.lastname: Williams
authors.forename: C L
authors.initials: CL
authors.lastname: Barsuhn
authors.forename: T J
authors.initials: TJ
authors.lastname: Raub
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D002460:Cell Line; D002746:Chlorpromazine / Q000493:pharmacokinetics*; D002839:Chromans / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D016166:Free Radical Scavengers; D008297:Male; D008567:Membranes, Artificial; D009961:Orosomucoid / Q000378:metabolism; D010539:Permeability; D010879:Piperazines / Q000494:pharmacology; D011281:Pregnatrienes / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D012710:Serum Albumin, Bovine / Q000378:metabolism
chemical_list: D000975:Antioxidants; D001798:Blood Proteins; D002839:Chromans; D016166:Free Radical Scavengers; D008567:Membranes, Artificial; D009961:Orosomucoid; D010879:Piperazines; D011281:Pregnatrienes; C066382:U 78517F; D012710:Serum Albumin, Bovine; D002746:Chlorpromazine; C053355:tirilazad